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Intercellular signaling molecules such as cytokines and their receptors enable immune
cells to communicate with one another and their surrounding microenvironments.
Emerging evidence suggests that the same signaling pathways that regulate
inflammatory responses to injury and disease outside of the brain also play powerful
roles in brain development, plasticity, and function. These observations raise the question
of how the same signaling molecules can play such distinct roles in peripheral tissues
compared to the central nervous system, a system previously thought to be largely
protected from inflammatory signaling. Here, we review evidence that the specialized roles
of immune signaling molecules such as cytokines in the brain are to a large extent shaped
by neural activity, a key feature of the brain that reflects active communication between
neurons at synapses. We discuss the known mechanisms through which microglia, the
resident immune cells of the brain, respond to increases and decreases in activity by
engaging classical inflammatory signaling cascades to assemble, remodel, and eliminate
synapses across the lifespan. We integrate evidence from (1) in vivo imaging studies of
microglia-neuron interactions, (2) developmental studies across multiple neural circuits,
and (3) molecular studies of activity-dependent gene expression in microglia and neurons
to highlight the specific roles of activity in defining immune pathway function in the brain.
Given that the repurposing of signaling pathways across different tissues may be an
important evolutionary strategy to overcome the limited size of the genome,
understanding how cytokine function is established and maintained in the brain could
lead to key insights into neurological health and disease.
Keywords: brain, synapse, microglia, cytokine, neural activity, sensory experience, developmentINTRODUCTION
The secretion of soluble signaling proteins by immune cells (e.g. macrophages, circulating
monocytes, and lymphocytes) and the activation of their cell-surface receptors via ligand binding
regulate many important processes throughout the body. Over the past 50 years, immunologists
have profiled a vast array of immune signaling pathways (broadly referred to as cytokines and
cytokine receptors) that mediate distinct functions in a highly context-dependent and tissue-specific
manner. This large family of signaling pathways, broadly defined, includes tumor necrosis factors
(TNFs), interferons (IFNs), chemokines, colony stimulating factors (CSFs), interleukins (ILs),org July 2021 | Volume 12 | Article 7035271
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proteins (MHCs), and their many and varied receptors. These
pathways allow immune cells to shape a host of critical processes
within target tissues, including cell proliferation, cell migration,
angiogenesis, inflammation, and tissue damage and repair (1).
Although many of these functions involve core mechanisms
shared across biological systems, the downstream molecular
changes and functional outcomes elicited by cytokine signaling
pathways can also vary significantly from tissue to tissue.
The functional adaptability of cytokines to different contexts
may represent a critical biological strategy to overcome the size
limits of the genome through the molecular repurposing of a
defined number of signaling molecules. Nowhere is the need for a
rich repertoire of specialized signaling mechanisms more
apparent than in the central nervous system (CNS), comprised
of the brain and spinal cord. Despite making up only ~2% of total
body weight, the brain uses ~20% of the body's energy, consistent
with the brain being constantly engaged in highly active
functions (2–4). Moreover, the precise establishment of the
brain's complex anatomy during development, including
cellular organization and synaptic connectivity, requires a host
of signaling mechanisms specific to age, cell type, and subregion
of the brain. Although signaling networks such as ephrins and
semaphorins are known to coordinate many aspects of neural
development and circuit wiring (5, 6), the vast complexity of the
brain suggests that these pathways represent a slim fraction of
signals used when it comes to molecular mechanisms underlying
neurological form and function. This observation underscores
the need for a systematic characterization of the myriad signaling
pathways that organize the brain.
While the roles of cytokines outside of the brain have been
studied for decades, their functions in the healthy brain have been
unexplored until relatively recently. This is in large part due to a
long and widely held understanding of the brain as an
"immunologically privileged" site in which the neurovasculature,
surrounded by a specialized cellular scaffold called the blood-
brain barrier (BBB), is largely impenetrable not only to circulating
immune cells but to soluble cytokines as well (7). This classical
view has shifted over the past ~15 years thanks in large part to two
discoveries: (1) canonical pro-inflammatory cytokines such as
TNFa, IFNg, and IL-1b regulate synaptic transmission between
neurons (8, 9); [reviewed (10, 11)], and (2) the resident immune
cells and predominant cytokine expressers of the CNS, microglia,
play an astoundingly wide array of previously unappreciated roles
in the healthy brain (12, 13). Yet, it remains to be determined how
microglia and cytokines play such specialized roles in the
development and function of the CNS compared to their roles
in the context of immunity.
Tissue-specific signals are likely to control at least some aspects
of cytokine function, and one particular signal that is largely
unique to the CNS is neural activity. When a neuron receives
information from another neuron in the form of chemical
neurotransmission at the synapse (i.e. the presynaptic release of
a neurotransmitter onto specialized receptors in the postsynaptic
membrane), this chemical signal is transduced into an electrical
signal. The electrical signal then propagates across the neuron'sFrontiers in Immunology | www.frontiersin.org 2membrane and ultimately results in the subsequent release of
neurotransmitter onto downstream neurons, leading to the
electro-chemical information flow of the brain. Neural activity is
a broad term encompassing the propagation of these electro-
chemical impulses across and between individual and/or
networks of neurons, and changes in neural activity can alter the
amount of neurotransmitter released at the synapse as well as the
conformation, ion conductance, and density of neurotransmitter
receptors in the postsynaptic membrane. Other consequences of
neural activity include the activation of dynamic calcium (Ca2+
(fluctuations that signal from the synapse to the nucleus to
coordinate stereotyped gene programs encoding critical
molecular regulators of synaptic connectivity and function (14).
Therefore, electrical activity and downstream neurotransmitter
release are associated with defined molecular and cellular changes.
As the primary means of information transfer across neural
circuits, activity regulates virtually all aspects of neurological
function. Therefore, activity is a promising candidate factor to
shape microglial and cytokine function in the brain. Indeed,
emerging evidence suggests that microglia and cytokines not
only participate in neurological processes that are powerfully
controlled by activity, but that the roles of microglia and
cytokines in the brain rely upon their ability to respond to
changes in activity. Here, we review the most recent evidence
that neural activity coordinates microglial and cytokine function
in the brain. We also discuss the implications of these activity-
dependent, cytokine-mediated processes for neurological
function, describe the aspects of these processes that remain
under active investigation, and discuss the most pressing
questions that have yet to be addressed about the roles of
immune signaling pathways in the CNS.MICROGLIAL FUNCTION IS SHAPED BY
ACTIVITY
Unlike neurons and other brain cells, microglia originate from an
erythromyeloid progenitor pool in the yolk sac, migrate into the
embryonic brain before the BBB is formed, and protect the brain
from injury and disease by clearing damaged tissue through
phagocytic engulfment (12). While microglia are not the only
cells in the brain that express cytokines and cytokine receptors,
mounting evidence reveals that they engage these pathways to
shape a host of critical and specialized brain functions including
neuronal apoptosis, synapse formation, synapse elimination,
circuit homeostasis, circuit plasticity, and complex behaviors
(15–20). Understanding how these signaling pathways that
coordinate inflammation in the periphery are repurposed to
perform highly specialized, non-injury induced functions in
the brain is key to establishing a systematic understanding of
the molecular basis of brain function. Moreover, based upon
evidence that immune dysfunction contributes to a host of
neurological disorders emerging across the lifespan (discussed
in more detail later), elucidating these mechanisms may facilitate
novel therapeutic strategies for treating human disease by
uncovering promising diagnostic biomarkers and drug targets.July 2021 | Volume 12 | Article 703527
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Manipulation of Activity
In vivo imaging of brain tissue in living mice via two-photon
microscopy is a rapidly evolving approach in neuroscience that
has been valuable in characterizing the physiological responses of
individual brain cells to diverse stimuli. In particular, functional
imaging of Ca2+ dynamics using genetically encoded Ca2+
sensors, such as Gcamp6, provides a readout of cellular
activation and has been extensively applied to neurons and
astrocytes, a non-neuronal brain cell type that is tightly
attuned to neural activity (21). Yet, until recently these Ca2+
imaging strategies had not been applied to microglia. In a
groundbreaking study, Umpierre et al. (22) performed
functional Ca2+ imaging in microglia of the somatosensory
cortex in live, unanesthetized mice. They discovered that
changes in neural activity initiated by exposure of the mice to
kainate, a seizure-inducing drug that drastically increases
activity, led to changes in Ca2+ dynamics within the highly
ramified and motile processes of microglia. More selective
bidirectional manipulation of neural activity through the
exogenous expression of either excitatory or inhibitory
Designer Receptors Exclusively Activated by Designer Drugs
(DREADDs), molecular tools for precisely manipulating neural
activity (23), in nearby neurons also produced tightly attuned
transient changes in Ca2+ dynamics within microglial processes.
Remarkably, Ca2+ dynamics localized to microglial processes
were induced within minutes of either an acute decrease or
increase in the activity of neighboring neurons, and the
patterning of these activity-induced Ca2+ fluctuations was
strikingly similar following either an increase or a decrease in
activity. These results are consistent with a role for microglia in
carefully monitoring activity at nearby synapses to maintain
circuit homeostasis, i.e. the balance of excitation and inhibition
present within a given circuit (22).
What impact does the functional coupling of microglial Ca2+
dynamics to neural activity have on the wiring of the brain?
While this is still being investigated, a number of structural live-
imaging studies lend support to the idea that microglia regulate
synaptic connectivity in an activity-dependent manner. For
example, in a resting state, microglia actively survey the
parenchyma of the cerebral cortex and directly contact
synapses about once per hour. Initially, cortical microglia were
shown to decrease synaptic contact frequency upon the
dampening of neural activity by local application of the activity
blocker tetrodotoxin (TTX) (20). Yet, this early finding has
recently been contradicted by more refined manipulations of
neural activity. For example, inhibiting activity through the
injection of the inhibitory neurotransmitter Gamma
Aminobutyric Acid (GABA)-agonist muscimol, suppression of
activity via optogenetic stimulation of inhibitory neurons, or
lowering overall neural activity using general anesthetics were
shown to increase microglial process surveillance and motility in
the somatosensory cortex (24). Consistent with this result, fixed
tissue studies of the retinogeniculate circuit, a pathway that
connects retinal ganglion cells (RGCs) in the eyes to the dorsal
lateral geniculate nucleus (dLGN) of the thalamus in the brain,Frontiers in Immunology | www.frontiersin.org 3showed that microglia are more likely to phagocytically engulf
synapses that have been silenced by TTX injection into the retina
as compared to unsilenced, active inputs (17). These data suggest
that decreasing activity can have versatile effects on microglia but
in most cases leads to increased contact between microglia
and synapses.
In parallel with studies employing artificial methods to inhibit
activity, several other studies have used pharmacological or
chemogenetic tools to assess the effects of heightened activity
on microglial function. For example, in the cortex, the frequency
of microglia-synapse contacts increases as a result of blocking the
inhibitory neurotransmitter GABA, a manipulation that
heightens neural activity (18). This result is consistent with
work showing that increasing neural activity using Bicuculline,
an antagonist of GABA, increases microglial motility overall
(18). Increasing neural activity through excitatory DREADDs
also increased the frequency of microglia-synapse contacts in the
striatum (25), indicating that this phenomenon is not selective to
cortex. Indeed, similar findings were observed in the
hippocampus, where exposure to kainate was shown to
increase microglial process convergence, a phenomenon in
which multiple microglial processes are simultaneously drawn
toward a specific synapse or group of synapses, which likely
reflects an increase in contacts between microglia and synapses
(22, 26–28). Induction of seizures with kainate also induced
changes in Ca2+ dynamics (22), active territory surveillance (26)
synaptic engulfment (28), and gene expression in microglia (25,
29), highlighting that microglia respond to increases in activity
by mechanisms that are largely similar to, but in some ways
distinct from, the effects of dampening activity (Figure 1). Given
that kainate raises activity enough to induce seizures, some of
these effects may reflect pathological changes and should thus be
interpreted carefully. Nevertheless, these findings highlight that
the functional responses of microglia to neural activity are
accompanied by robust structural and molecular changes. Just
as neural activity drives changes in microglia, microglia also
provide feedback to neurons, for example through the
conversion of adenosine triphosphate into adenosine which
leads to suppression of neural synchrony and firing (25).
Consistent with bidirectional interactions between microglia
and neurons being organized by activity, microglia are also
required for learning-dependent spine turnover in motor
cortex, further suggesting that microglial function is tightly
linked to activity-dependent processes in the brain (30).Microglial Responses to the Manipulation
of Sensory Experience
While pharmacological, chemogenetic, and optogenetic methods
for altering neural firing have provided compelling evidence that
microglia can sense and respond to activity, howmicroglia respond
to physiologically relevant stimuli such as sensory experience is an
ongoing topic of research. It is now well understood that microglia
in the visual system routinely contact and eliminate synaptic
elements such as presynaptic boutons and postsynaptic structures
called dendritic spines (17, 20). Deprivingmice of visual experienceJuly 2021 | Volume 12 | Article 703527
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increase in microglia-synapse contact frequency and an increase in
the engulfment of neuronal material, as well as the expansion of
microglial processes in visual cortex. Interestingly, re-exposure of
mice to light following a period of dark-rearing also increased the
number of microglia-synapse contacts compared to normally
reared mice (31), consistent with the observation that microglial
calcium signaling is similarly induced by either a decrease or an
increase in activity (22).On the otherhand, themotility ofmicroglia
was decreased by dark-rearing but increased by re-exposure of
dark-reared mice to light, suggesting that distinct mechanisms
induce microglia-synapse interactions in each case (31).
The contribution of microglia to experience-dependent
developmental plasticity within the brain is not restricted to
the visual cortex. For example, in the dLGN, the elimination of
synapses during the third week of postnatal life, a stereotyped
developmental process that requires visual experience, also
requires cytokine signaling by microglia (32). Similarly, sensory
experience in the somatosensory cortex, a brain region that
processes tactile information, also shapes microglial function.
For example, depriving adult mice of experience by whiskerFrontiers in Immunology | www.frontiersin.org 4trimming (i.e. removing sensory information mediated by facial
whiskers) leads to increased process surveillance and motility by
microglia, suggesting that, when experience is dampened,
microglia may spend more time and energy seeking active
synapses (24). In young mice, at P4-5 when the cortical
territories for each whisker are still being formed, sensory
deprivation by whisker lesioning induces microglial engulfment
of thalamic inputs to cortex, a process that requires fractalkine
signaling from neurons to microglia and results in the functional
refinement of thalamocortical connectivity (33). Therefore, in
both the visual system and the somatosensory system,
manipulating sensory experience leads to diverse, bidirectional
changes in microglial motility and contact with synapses.
Altogether, these imaging data highlight that the roles of
microglia in synapse development and plasticity are likely to be
reliant upon robust microglial detection of changes in neural
activity within their microenvironments. Yet, a caveat to be taken
into consideration is that many of these studies were performed
in mice anesthetized with either isoflurane or ketamine, drugs
that suppress neural activity overall and which Umpierre et al.
















































FIGURE 1 | Microglia respond to changes in neural activity. In a resting state, microglia (blue) actively survey the neural environment, dynamically contacting
synapses (presynaptic terminals in red, postsynaptic dendrites and spines in teal). Artificial manipulation of neural activity by pharmacological, chemogenetic, or
optogenetic perturbation leads to robust changes in microglial calcium dynamics (shown in yellow), process motility, synaptic contact frequency, and transcription.
Depriving mice of or exposing mice to sensory stimuli affect many of the same aspects of microglial function. These data are consistent with an important role for
microglia in establishing and/or maintaining circuit stability and homeostasis.July 2021 | Volume 12 | Article 703527
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interpretation of these results, we provide annotation in
Table 1 of which live-imaging studies were performed in
anesthetized versus awake mice. Despite this caveat, this
expanding body of work demonstrates that many features of
microglial function - e.g. Ca2+ dynamics, contact with synapses,
and process motility – can be similarly affected by either
decreased or increased activity, indicating a potential role for
microglia in balancing and maintaining circuit homeostasis
(Figure 1). This observation suggests that microglia may be
just as important for synapse formation, strengthening, and
maintenance as they are for synapse elimination. Further
studies are required to better understand how microglia work
in concert with neural activity to regulate synaptic connectivity
and homeostasis, as well as to determine the contributions of
microglia to more global aspects of neural circuit function
beyond the local regulation of synapses.Frontiers in Immunology | www.frontiersin.org 5CYTOKINE SIGNALING IN
NEURODEVELOPMENTAL PROCESSES
SHAPED BY ACTIVITY
A body of live-imaging and fixed tissue studies demonstrate that
microglia function in concert with neural activity to shape brain
wiring. While the molecular mechanisms governing this process
have not yet been extensively defined, microglia are derived from
an immune cell lineage which makes canonical immune
signaling molecules appealing candidates to link microglia to
activity-dependent changes at synapses. Furthermore, evidence
suggests that immune signaling molecules in the brain are not
exclusively expressed by microglia, indicating that non-immune
cells like neurons and other non-neuronal glial cells could also
engage these powerful molecular pathways to drive neurological
function. Below, we review evidence that intercellular signaling
pathways associated with immune responses in the periphery areTABLE 1 | Microglia respond to changes in neural activity by altering their motility and interactions with synapses.
Activity perturbation Effect on microglia Mechanism/
Mediator
Brain region Anesthetic used Citation




Norepinephrine SS (somatosensory) cortex None Liu et al. (24)
Decreased neural activity
(TTX)
Increased synaptic engulfment Complement
pathway (C1/Cr3)
dLGN Fixed tissue Schafer et al.
(17)




Unknown SS cortex None Umpierre et al.
(22)
Decreased neural activity
(TTX, decreased body temp.)












SS cortex Fixed Tissue Gunner et al
(33)
Increased neural activity (glutamate,
kainate)
Increased process extension P2Y12 Hippocampus (Ex vivo) and
SS cortex (in vivo)
Unknown Eyo et al. (27)









Unknown SS cortex None Umpierre et al.
(22)










Striatum None Badimon et al.
(25)
Increased neural activity
(Gq DREADD) or ischemia
Increased somatic contact P2Y12 Cortex Fentanyl Cserép et al.
(34)
Increased neural activity (kainate) Change in gene expression Unknown Hippocampus N/A Bosco et al.
(29)
















Decreased neural surveillance THIK-1 Cortex Urethane Madry et al.
(18)July 2021 | Volume 12 | Article 703527
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and plasticity in a manner that depends upon age, circuit, and
pattern of activity.
The Classical Complement Cascade
The roles of immune signaling molecules in brain development
have been extensively studied in the retinogeniculate circuit of the
mouse. This connection between the axons of RGCs in the eye and
their thalamic postsynaptic targets, the relay neurons of the dLGN,
undergoes a robust period of circuit refinement spanning the first
month of postnatal life that involves a progressive decrease in the
number of retinogeniculate synapses and a concurrent increase in
the strength of the remaining connections (35–38). Retinogeniculate
refinement can be broken down into separate activity-dependent
phases which are mediated by distinct immune signaling pathways,
beginning with eye-specific segregation (ESS) that starts at birth and
culminates around P7 in mice. During this phase, inputs deriving
from RGCs in the ipsilateral and contralateral eyes that synapse
onto the same territory in the dLGN are selectively eliminated,
leading to the anatomical segregation of ipsi- and contralateral
synapses. Terminating prior to the onset of visual experience at eye-
opening, ESS is driven by intrinsically generated neural activity
propagated to the dLGN from the retina (39). The first evidence that
this early stage of refinement in the dLGN involves immune
signaling mechanisms emerged in 1998 from an elegant study
from the lab of Dr. Carla Shatz which showed that class 1 MHC
proteins are expressed in dLGN neurons in an activity-dependent
manner and are required for ESS (40). This and subsequent related
studies on the roles of MHC molecules in synaptic refinement (41–
43) opened a new line of investigation into interactions between
immune pathways and developing synapses, paving the way for Drs.
Ben Barres and Beth Stevens to discover key roles for the classical
complement cascade (ccc) in retinogeniculate refinement.
The ccc is an innate immune pathway that mediates
phagocytosis in peripheral tissues and in the brain. In the
CNS, microglia initiate the cascade by releasing the secreted
molecule complement component 1q (C1q), which binds dead
cells, debris, or even synapses and triggers the synaptic
deposition of the downstream complement component 3 (C3).
C3 deposited on synapses is recognized by the CR3 receptor
expressed by microglia which induces microglia to phagocytose
the complement-tagged synaptic material thereby disassembling
functional synapses.
Roles for the ccc in synapse elimination have been best
demonstrated in the retinogeniculate circuit, where the ccc is
critical for ESS and the continuing refinement of retinogeniculate
connectivity. Originally identified in a screen for neuronal genes
expressed in cultured RGCs upon exposure to astrocyte-derived
media, C1q was not only shown to be expressed in the retina but
also in the dLGN where it localizes to developing retinogeniculate
synapses in wild-type (WT) mice. ESS is disrupted in mice lacking
C1q or C3 such that ipsi- and contralateral retinal inputs are not
appropriately segregated in the knockout (KO) mice. In addition
to impairments in ESS, C1q KO mice also exhibit
electrophysiological refinement deficits that persist at least until
P30 when the circuit is largely mature, resulting in the
retinogeniculate circuits of C1q KO mice maintaining an excessFrontiers in Immunology | www.frontiersin.org 6of weak synapses compared to wild type counterparts (44).
Although initially identified in cultured RGCs, C1q and C3 are
enriched in microglia in vivo, suggesting a role for these immune
cells in eliminating developing synapses through phagocytic
engulfment. Indeed, microglia from mice lacking C1q, C3, or
CR3 phagocytose less synaptic material than their WT
counterparts, indicating that the ccc drives synapse elimination
by triggering synaptic engulfment by microglia, consistent with
the nature of microglia as specialized myeloid cells (Figure 2A)
(17). Interestingly, regulation of ESS by the ccc also requires
Transforming Growth Factor beta (TGFb) signaling in the retina,
highlighting that cross-talk between distinct immune signaling
axes is perhaps an additional mechanism through which
cytokines perform distinct functions dependent upon context
(45). Together, these studies demonstrated novel roles for the ccc
and microglia in developmental synapse elimination.
Following up on these studies in the dLGN, the ccc has also
been shown to regulate synaptic connectivity in cortical slices
(46), and to promote developmental synapse elimination in the
ventral thalamus (47) and the spinal cord (48). Moreover, ccc
function is not restricted to development but has also been
strongly linked to age-dependent synaptic changes in the
hippocampus, a widely studied brain region associated with
learning and memory (19, 47, 49). Loss of C1q leads to
synaptic deficits in hippocampal neurotransmission and
cognitive and behavioral impairments linked to hippocampal
function in adult mice (47). Supporting evidence for the role of
C1q in adult hippocampal function was found by Wang et al.
(19), who show that microglia mediate hippocampal synapse
loss, allowing mice to forget features of their environment that
are not critical to their survival. Moreover, a growing body of
literature implicates C1q as an early driver of synapse loss in
neurodegeneration and other inflammatory brain conditions
affecting the hippocampus (50–53)[reviewed in (54)]. Despite
the multiple processes known to be regulated by the ccc in the
brain, the pathway is not universal but rather functions in a
circuit-specific manner. For example, the ccc is dispensable for
the microglia-driven development of the whisker barrels in
somatosensory cortex (33), sensory experience-dependent
ocular dominance plasticity in visual cortex (55), and synapse
elimination during a late phase of experience-dependent
refinement in the dLGN that takes place between P20 and P30
(32)(Figure 2B). These data suggest that the ccc is not a
ubiquitous regulator of synapse elimination but rather that the
ccc pathway plays precise roles at synapses across a subset of
circuits depending upon the age of an organism. This leaves
room for other immune signaling pathways to join the ccc as
critical regulators of brain development and function.
Cerebellins and C1q-Like Proteins
One brain region in which synaptic refinement is not thought
to require the ccc or microglia is the cerebellum, a posterior
brain structure important for motor coordination among many
other functions. Purkinje cells (PCs), a population of
GABAergic neurons that are the major output of the
cerebellar cortex, receive synaptic input from two main
excitatory sources: climbing fibers (CFs) emerging fromJuly 2021 | Volume 12 | Article 703527
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fibers (PFs) emerging from granule cells (GCs) whose somata
reside in the granule cell layer of the cerebellum. Like the
retinogeniculate pathway, the Parallel Fiber-to-Purkinje Cell
(PF-to-PC) and the Climbing Fiber-to-Purkinje Cell (CF-to-
PC) pathways consist of stereotyped innervation patterns that
emerge during development through activity-dependent
mechanisms (56). Hence, the cerebellum joins the dLGN as a
powerful model system in which to study activity-dependent
aspects of neural circuit development.
Like the retinogeniculate circuit, the refinement of the CF-to-
PC connection entails the removal of a large number of synapses
and the maintenance of only a few innervations. Initially,
multiple CFs provide relatively weak innervation to the soma
of each PC. Between P3 and P7, only one of these inputs is
strengthened at which point its synaptic terminals translocate
from the soma to the proximal dendrites of the postsynaptic PC.
Subsequent to the translocation of the strengthened input, the
weak CF inputs remaining on the soma are eliminated across an
early stage (P7–P11) and a late stage (P12-P17), leaving only a
single CF innervation to each PC. Furthermore, the late stage
elimination requires the normal development and establishment
of PF-to-PC synapses onto distal PC dendrites (57). The C1q-like
1 (C1ql1) cytokine, which derives its name from its structural
similarity to complement proteins, acts directly at CF-to-PC
synapses to promote single CF strengthening and to drive the
elimination of the CF inputs that fail to strengthen. C1ql1Frontiers in Immunology | www.frontiersin.org 7expressed by presynaptic climbing fibers enforces this one-to-
one innervation pattern between a CF and a PC by binding to the
PC-expressed receptor Brain-specific angiogenesis inhibitor 3
(Bai3) that localizes to postsynaptic sites (58). These results
underscore that cytokines can be employed to shape brain
development through neural-specific mechanisms that don't
directly involve microglia.
Cerebellins are another class of cytokines structurally related
to both C1q and C1ql1 that play an important role in activity-
dependent circuit refinement in the cerebellum. Upon its
secretion from granule cells, Cerebellin-1 (Cbln1) orchestrates
the assembly of PF-to-PC synapses during the third week of life.
Mice lacking Cbln1 exhibit deficits in motor coordination
corresponding with decreases in both the number and the
strength of PF-to-PC synapses. Interestingly, the translocation
of PF-to-PC synapses onto the distal dendrites of the PC is
required for the development of CF-to-PC synapses, which is
activity-dependent (59). Consistent with the requirement of PF-
to-PC neurotransmission for CF-to-PC refinement, mice lacking
Cbln1 aberrantly maintain PC innervations from multiple CFs
into maturity (60). These deficits were strikingly similar to those
observed upon the loss of GluRd2, a glutamate neurotransmitter
receptor subunit expressed at the postsynaptic sites of PCs
during development. Indeed, the structural and functional
development of PF-to-PC synapses was shown to require a
direct interaction between postsynaptic GluRd2, soluble Cbln1,































FIGURE 2 | Cytokine pathways coordinate brain development and plasticity in a region- and age-dependent manner. (A) In the dLGN of the thalamus, the classical
complement cascade (ccc) mediates the phagocytic engulfment of synapses (presynaptic inputs in red, postsynaptic dendrites and spines in teal) by microglia (blue)
between birth and P7. (B) During a later period of experience-dependent refinement in the dLGN, TWEAK-Fn14 signaling from microglia to neurons disassembles
synapses, while Fn14 functions in the absence of its ligand TWEAK to strengthen synaptic connections. (C) In the cerebellum, the cytokine Cbln1 binds presynaptic
Neurexin and the postsynaptic neurotransmitter receptor GluRd2 to establish parallel fiber – to – Purkinje cell synapses independently of microglia. (D) IL-33 to
Interleukin 1 receptor-like 1 signaling mediates experience-dependent synaptic plasticity in the hippocampus by inducing microglia to engulf the extracellular matrix.
(E) Fractalkine signaling from neurons to microglia establishes somatosensory whisker territories via microglial engulfment of thalamocortical inputs.July 2021 | Volume 12 | Article 703527
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machinery, is able to control synapse formation and
refinement in the cerebellum (Figure 2C). Cbln1, -2, and -4
are also expressed in parts of the brain other than the cerebellum
and double and triple Cbln family member KO mice exhibit
synaptic changes in brain regions such as the cortex and the
thalamus, indicating more general roles for these immune
signaling molecules in the developing brain that are yet to be
described (64).
Interleukins
Interleukins (ILs) represent another broad class of immune
signaling molecules that are expressed in the brain. Two recent
studies from the lab of Dr. Anna Molofsky have identified the
cytokine IL-33 and its receptor Il1rl1 as important organizers of
circuit development andplasticity acrossmultiple brain regions. IL-
33 was discovered as an astrocyte-derived, developmentally
upregulated cytokine that binds its receptor Il1rl1 on microglia to
dampen oscillatory activity in the thalamus. Constitutive KO of IL-
33 in mice caused an increase in spontaneous neural firing and
enhanced evoked activity in response to thalamic stimulation,
suggesting an aberrant increase in the number of synapses (65).
More precise deletion of IL-33 only in astrocytes led to an increased
number of both excitatory and inhibitory synapses onto a-motor
neurons, the primary output neurons of the sensorimotor circuit in
the spinal cord. A similar effect was seen in mice constitutively
lacking IL-33 or its receptor Il1rl1. In the spinal cord, deletion of IL-
33 also decreased the amount of synaptic material found within the
cellular boundaries of microglia, suggesting that IL-33 functions to
eliminate synapses by inducing phagocytic synapse engulfment.
Consistent with this result, local injection of IL-33 into either
thalamus or spinal cord increased the amount of synaptic
material found within microglia. Altogether, these data identify
IL-33 as an astrocytic cytokine that binds its receptor Il1rl1 on
microglia to decrease synapse number and strength acrossmultiple
circuits (65).
The expression pattern and role of IL-33 in thalamic and
spinal cord development contrast its function in the adult
hippocampus. Unlike the developing dLGN in which IL-33 is
expressed in astrocytes, in the hippocampus IL-33 is derived
from neurons and its neuronal expression is increased in
response to environmental enrichment (EE), a physiological
paradigm that results in heightened levels of neural activity
(66). Loss of either IL-33 or its receptor Il1rl1 decreased spine
density overall as well as the number of spines with dynamic
filopodia, suggesting that IL-33-Il1rl1 signaling between active
neurons and local microglia promotes EE-induced new spine
formation and plasticity. Intriguingly, microglia were found to
induce these synaptic changes by engulfing the extracellular
matrix (ECM) component Aggrecan in an IL-33-dependent
manner, as loss of IL-33 results in an inappropriate
accumulation of Aggrecan at postsynaptic sites. Altogether,
these data support that cytokine signaling between neurons or
astrocytes and microglia is coordinated to shape synaptic
connectivity in response to environmental stimuli in
mice (Figure 2D).Frontiers in Immunology | www.frontiersin.org 8Tumor Necrosis Factors
The TNF superfamily is composed of 19 membrane-tethered or
soluble ligands and 29 cell-surface receptors that mediate
intercellular signaling between multiple cell types. TNF ligand-
receptor binding elicits a variety of cellular processes including
cell proliferation, cell migration, angiogenesis, inflammation, and
apoptosis via a number of signaling cascades including NF-kB
and MapK. Although the canonical family member, TNFa, has
been shown to mediate synaptic strengthening and
neurotransmission (8), roles for other members of this large
family in the brain remain to be fully explored.
Following initial stages of refinement that rely upon
spontaneous retinal activity, the retinogeniculate circuit
undergoes a critical period of refinement during the third week
of life that is powerfully controlled by visual experience. Given that
the ccc regulates phases of retinogeniculate refinement that
culminate prior to this period, until recently, whether and how
cytokines contribute to this late phase of development had yet to
be resolved. Because it was previously observed that the phagocytic
activity of microglia decreases drastically around P7, a prevailing
view was that microglia do not participate in this late phase of
sensory-dependent refinement in the dLGN.
Thisviewwas recently challengedby thediscoveryof aTNF family
cytokinepathway that controls late-stage retinogeniculate refinement.
Inan invivo single-cellRNA-sequencing screen for genes expressed in
dLGN neurons in response to visual experience during this late stage
of development,Cheadle et al. (67) discovered that visually stimulated
neurons strongly increase the expression of the gene encoding the
TNF receptor superfamily member Fibroblast Growth Factor-
inducible protein 14 kDa (Fn14, also known as TNF receptor
superfamily member 12a) (67). Intriguingly, visual stimulation
concurrently induces the expression of the ligand of Fn14, the TNF
superfamily member TNF-associated Weak Inducer of Apoptosis
(TWEAK), in a subset ofmicroglia in the dLGN (32).While the roles
of TWEAK-Fn14 signaling outside of the brain in processes such as
muscular degeneration, cell proliferation, angiogenesis, and
inflammation have been extensively characterized, virtually nothing
was known about the roles of this pathway in the healthy brain (68).
Through a combination of electrophysiological, ultrastructural,
and molecular approaches applied to the retinogeniculate circuit,
the authors found that Fn14 functionswhennot boundbyTWEAK
to strengthen retinogeniculate connectivity by increasing the
number of synapses. However, at retinogeniculate synapses near
the subset of stimulatedmicroglia that express TWEAK,microglia-
derived TWEAK binds Fn14 to trigger the deconstruction of
dendritic spines and ultimately remove functional synapses (32,
67). Notably, TWEAK and Fn14 are dispensable for early stages of
retinogeniculate refinement including ESS which is coordinated by
the ccc (17). Likewise, phagocytic engulfment of synapses occurs
normally in mice lacking TWEAK or Fn14 across all time points.
Thus, TWEAK-Fn14 signaling selectively coordinates a late-stage
of sensory experience-dependent synapse refinement through a
microglia-driven, non-phagocytic mechanism of synapse
elimination (Figure 2B).
Whereas ccc and IL-33 signaling play varied roles across
multiple neural circuits, until recently it was not known whetherJuly 2021 | Volume 12 | Article 703527
Ferro et al. Microglia, Cytokines, and Neural ActivityTWEAK-Fn14 signaling extends beyond the retinogeniculate
synapse to remodel other circuits during development or in the
adult, and whether this pathway may also be relevant to disease.
A recent study by Nagy et al. (69) showed that exogenous
application of recombinant TWEAK dampens long-term
potentiation, a measure of activity-dependent synaptic
strengthening, in the hippocampus. Moreover, suppression of
endogenous TWEAK using blocking antibodies ameliorated
Fn14-dependent synaptic deficits in mouse models of stroke
and Alzheimer's disease, indicating not only that the TWEAK-
Fn14 pathway is an important synaptic organizer across multiple
circuits in the brain but also that disruptions in TWEAK-Fn14
signaling may contribute to neurological dysfunction related to
brain disorders. Therapies focused on interfering with TWEAK-
Fn14 signaling may therefore have potential for treating
neurodegeneration and stroke-related illness.
Fractalkine
While complement plays multifaceted roles in the hippocampi of
mature mice, evidence linking complement to the development
of hippocampal circuitry is lacking. Instead, research points to
signaling between the neuronal chemokine Fractalkine
(CX3CL1) and its microglia-expressed receptor, CX3CR1, as
mediators of synapse development in the hippocampus. In
contrast to the pathways thus far described, CX3CL1 and
CX3CR1 are both highly enriched in the brain where they have
been shown to play a wide variety of roles related to brain health
and function [reviewed in (70)] including: the migration and
colonization of microglia within the hippocampus (16), neuronal
survival (71, 72), microglial morphology and motility (73),
maturation of inhibitory and excitatory synapses (74), and
functional neurotransmission (75–78). Many of these deficits
arise within the first three weeks of life at a time when excess
hippocampal synapses are undergoing activity-dependent
pruning (79). Animals lacking CX3CR1 maintain an excess of
hippocampal CA1 synapses exhibiting decreased synaptic
strength compared to WT, suggesting a concurrent
impairment in synapse elimination and an inability of synapses
to properly mature in the absence of fractalkine signaling (16,
78). These deficits in synaptic connectivity persist into adulthood
and are accompanied by reduced local field potentials and altered
social interactions (80).
Similar to the ccc, fractalkine signaling is largely dispensable
for visual cortex development in vivo, as visual acuity,
experience-dependent synaptic potentiation, and ocular
dominance plasticity are all normal in mice lacking CX3CR1
(81). Likewise, microglial morphology, density, motility, and
interactions with synapses in V1 are also unchanged by loss
of CX3CR1 (82). On the contrary, studies in somatosensory
cortex have revealed a requirement of fractalkine signaling
for the recruitment of microglia to "barrels", clusters of
thalamocortical (TC) inputs that correspond to the territory
selectively innervated by each whisker, between P5 and P7.
CX3CR1 is also required for the functional maturation of TC
connectivity, the pruning of excess TC inputs that occurs in
response to sensory lesioning, and experience-dependent
synaptic remodeling (33). Fractalkine KO mice and miceFrontiers in Immunology | www.frontiersin.org 9subjected to pharmacological inactivation of Adam10, a
metalloprotease that cleaves CX3CL1 into a soluble form
enabling it to bind its microglial receptor, both show similar
deficits in synapse pruning and maturation as those observed in
the CX3CR1 KO (Figure 2E). Notably, this study found C1q to
be dispensable for synapse development in somatosensory
cortex, highlighting that different immune pathways are
specialized to regulate distinct circuits (33). Altogether, these
detailed studies across a multitude of circuits in the brain show
that activity-dependent processes are controlled by microglia and
cytokine signaling.ACTIVITY-DEPENDENT EXPRESSION OF
CYTOKINES IN THE BRAIN
Now that it is becoming clear that activity shapes microglial and
cytokine function, it is important to disentangle the mechanisms
underlying this process. Emerging data suggest that one way in
which activity influences cytokine function is through tight
control of cytokine and cytokine receptor expression.
Supporting this possibility, signaling between TWEAK and
Fn14, a cytokine pathway through which microglia remove
developing synapses in the dLGN as described above, is
coordinated by the concurrent transcriptional induction of
each signaling partner in microglia and neurons, respectively,
in response to visual stimulation. The result that microglia
induce TWEAK expression in response to experience was
remarkable because, while neurons have been known to
mount transcriptional responses to sensory cues for decades, it
was not expected that an immune population such as microglia
may also respond at such a fundamental level to sensory
information from the external world. An interesting feature of
the sensory-dependent induction of TWEAK expression in
microglia is its restriction to a subset of microglia, which
suggests heterogeneity in the responses of microglia to a given
stimulus and indicates that different microglia within the same
tissue may perform different functions depending upon the
cytokines that they express. Consistent with such functional
heterogeneity, retinogeniculate synapses nearby microglia that
induce TWEAK are more likely to be eliminated than
retinogeniculate synapses near microglia that do not induce
TWEAK. In contrast to TWEAK expression in microglia, Fn14
induction occurred across all excitatory neurons in the dLGN,
suggesting that at least in this context neuronal responses to
experience are more stereotyped and synchronous than the
responses of microglia. The difference in gene induction is not
unexpected, as neurons are directly activated by synaptic
transmission while microglia are likely to be activated through
less direct pathways, such as molecular signals from active
neurons. Overall, these data highlight that the transcriptional
control of cytokine and cytokine receptor expression across
different cell types is one way in which activity determines
cytokine function.
These studies of TWEAK and Fn14 indicate that sensory
stimuli can induce the cell-type-specific expression of cytokineJuly 2021 | Volume 12 | Article 703527
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distinct cell types (32). Intriguingly, further analysis of the single-
cell transcriptomic dataset profiling experience-dependent genes
in dLGN neurons showed that Fn14 is not the only immune
signaling molecule whose neuronal expression depends upon
activity. For example, Fractalkine (CX3CL1) is also highly
induced in neurons (the same neurons that induce Fn14) in
response to visual stimulation, suggesting that fractalkine
signaling from neurons to microglia is another circuit-specific
example of experience controlling cytokine function. Yet another
example of experience-dependent neuron to microglia cytokine
signaling is found in the hippocampus, where increased sensory
stimulation through EE induces IL-33 expression in neurons
which binds its Il1rl1 receptor in microglia to engage microglia in
synaptic plasticity (66). Thus, inducible transcription of
cytokines is one method through which heightened neural
activity can precisely control cytokine signaling from microglia
to neurons, and vice versa.
In addition to the direct transcriptional control of cytokine
and cytokine receptor expression, neural activity may also
mediate aspects of cytokine signaling between partners whose
expression is activity-independent. An excellent example of this is
found in the developing somatosensory cortex, where Gunner et
al. (33) discovered that, although CX3CL1 and CX3CR1
expression does not require experience, fractalkine signaling is
controlled by experience via the induction of the expression of
Adam10 in layer 4 neurons. Adam10 is a metalloprotease that,
among other functions, cleaves neuronal CX3CL1 into its soluble
form. Upon cleavage, soluble CX3CL1 binds CX3CR1 in
neighboring microglia to induce synaptic pruning of
thalamocortical inputs through phagocytic engulfment. This
process thereby anatomically segregates distinct "barrel"
regions of cortex innervated by independent whiskers (33).
This intriguing finding opens up a host of other possible
methods through which activity may coordinate specialized
functions of cytokine signaling beyond direct transcriptional
control of the signaling components themselves. For example,
it will be interesting to determine whether the initiation of local
protein translation or the posttranslational modification of
microglial proteins are also regulated by activity.DISCUSSION: BROADER IMPACTS AND
NEW HORIZONS
It is now evident that cytokines are pleiotropic molecules that are
repurposed throughout the CNS to mediate synapse development,
plasticity, and function. However, the signals that maintain the
specialized roles of microglia and cytokines in the brain are still
being elucidated. Thus far, we reviewed evidence that neural activity
is a brain-specific influence on immune signaling pathways that, to a
large extent, determines their specialized functions in the CNS. Not
only are microglial Ca2+ dynamics, motility, and interactions with
synapses tightly and bimodally attuned to both increases and
decreases in activity, microglia and cytokines also play integral
roles in developmental and homeostatic processes that are activity-Frontiers in Immunology | www.frontiersin.org 10dependent. Although these data strongly suggest an important link
between activity and microglial/cytokine function, the direct
relationship between these two phenomena is not yet
well-established.
Given that microglia are non-neuronal immune cells that lack
intrinsic excitability and are not connected to sensory structures or
neurons at the synaptic level, howmicroglia initially detect changes
in neuronal activity is a question under active investigation. One
possible mechanism through which microglia may respond to
sensory stimulation is purinergic signaling. Upon stimulation,
neurons release purine nucleotides such as adenosine and ATP
which can act as signals to other cells such as microglia. The
purinergic Gi coupled receptor, P2y12, in conjunction with the
potassium channel TWIK-related halothane-inhibited K+ channel
(THIK-1), has been shown toplay critical roles in the recruitmentof
microglia toareasofhighactivity, anddeletionorblunt inhibitionof
either has been shown to increase overall neural activity and seizure
susceptibility, making P2y12/THIK-1 an ideal candidate for
mediating interactions between activity and microglia (25, 34).
Alongside P2y12/THIK-1's role in motility and suppression of
neural activity, evidence suggests that activation of the P2y12/
THIK-1 can induce the expression of inflammatory cytokine IL-
1b and the initiation of NLRP3 inflammasomes (83). Therefore,
P2y12/THIK-1 signaling is a strong candidate pathway for
initiation of cytokine release by microglia upon increases in
neural activity, and may prime microglia to remodel or remove
synapses via structural mechanisms like phagocytic engulfment
and/or contact-independent mechanisms like TWEAK-
Fn14 signaling.
Yet, it should be noted that this P2y12/THIK-1 signaling is likely
not the only pathway through which microglia both sense and
induce large-scale synaptic changes. For instance, microglia are
capable of directly monitoring levels of neurotransmitters and
neuromodulators through canonical neurotransmitter receptors
that microglia have been shown to express (84). Therefore, the
intracellular signaling cascades these neurotransmitter receptors are
coupled tomay dictate which cytokines themicroglial cell engages to
remodel neural connectivity. These mechanisms of direct response
to neurotransmitter release are consistent with the observation that
microglia are highly motile cells that constantly sample synapses
across the brain parenchyma. Another possibility is that heightened
activity in neurons leads to the transcription, translation, secretion,
and/or subcellular localization of non-neurotransmitter molecular
signals capable of binding receptors on microglia. When such
binding occurs, microglia may respond through intracellular
signaling events leading to a global change in transcriptional
profile. Finally, because changes in neurovascular blood flow,
structural complexity, and BBB integrity accompany changes in
neural activity, molecular signals from the blood or from the BBB
itself (comprised of endothelial cells, pericytes, and astrocytes) may
also inform microglia of changes in activity and recruit them to
remodel synapses in response (85, 86). Determining how microglia
sense changes in activity is therefore an important next step in
defining the specialized roles of cytokine signaling in the brain.
As described above, transcriptional upregulation of cytokines
and their receptors in both microglia and neurons has emerged asJuly 2021 | Volume 12 | Article 703527
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function. While much is known about the gene programs and
transcriptional mechanisms that coordinate activity-dependent
gene expression in neurons, much less is known about this
process in microglia. In addition to candidate-based approaches
studying TWEAK-Fn14 and IL-33 signaling, a recent study
investigated the gene programs induced in microglia of the
striatum following DREADD-mediated activation of neighboring
neurons. This approach identified multiple genes that are
upregulated or downregulated in microglia following neuronal
activation, including those that encode mediators of chemotaxis
and actin polymerization being upregulated and those encoding
baseline aspects of motility being downregulated (25). With the
growing number of approaches for analyzing transcriptomic and
genomic changes in individual cell types, the field is now poised to
systematically define the gene programs within neurons, microglia,
and other non-neuronal cells that are induced by activity. Moving
forward, it will be important to assess these changes not only in
response to artificialmanipulationofneural activity suchas through
chemogenetic, optogenetic, and pharmacological methods but also
in response tomorenaturalistic cues suchasvisual stimuli andEE. It
will also be critical to analyze the epigenomic changes, such as
chromatin accessibility and histone modification, that underlie the
transcriptional responses of microglia to activity.
The evidence reviewed here suggests that activity not only
influences microglial and cytokine function, but that cytokines
and microglia provide feedback to neurons that sculpts activity.
Thus, communication between activity and immune signaling
mechanisms in the brain is a two-way street. For example, upon
the transcriptional upregulation of TWEAK in microglia in
response to experience, TWEAK binds Fn14 at synapses to
remove them, thereby dampening neural activity in the dLGN
overall. Moving forward, it will be important to understand the
specific changes that cytokines elicit at synapses in order to shape
activity, a line of investigation that has the potential to reveal
roles for cytokines not only in local circuit homeostasis but also
computational aspects of brain function including sensory
integration and motor coordination. This research direction is
important for building upon studies elucidating the roles of
microglia and cytokines in organizing synapses locally by
assessing whether microglia can detect differences in activity
patterns driven by selective features of neural circuit function.
Finally, as mounting evidence suggests that immune dysfunction
contributes to neurological diseases arising across the lifespan, the
implications of cytokine function in the brain have taken on a new
translational urgency. For example, neurological diseases that are
highly correlated with neuroinflammation and cytokine
upregulation include Alzheimer's disease (AD), multiple sclerosis
(MS), and stroke. In a widely used mouse model of Alzheimer's
disease, C1q is deposited upon hippocampal synapses before the
onset of disease progression. This leads to the complement-
mediated, inappropriate phagocytosis of functional synapses by
microglia resulting in disease-linked synapse loss and cognitive
decline (50). Similarly, inhibiting TWEAK-Fn14 signaling in an AD
mouse model ameliorated deficits in synapse plasticity in the
hippocampus, suggesting that multiple immune pathways canFrontiers in Immunology | www.frontiersin.org 11contribute to the same pathological conditions that affect neural
connectivity (69). In a mouse model of MS, where synapse loss in
grey matter regions precedes axonal degeneration (independent of
demyelination) (87), genetic deletion of C3 can ameliorate both
microglial activation as well as neural dysfunction (88) suggesting
that targeting the complement system may have therapeutic
potential for treating chronic neuroinflammatory illnesses before
symptoms arise. The therapeutic potential of targeting cytokines is
not restricted to diseases of chronic neuroinflammation, but likely
extends to acute stroke models as well, given that targeting TNFs
(89) or ILs (90) ameliorates synaptic deficits in these conditions.
Therefore, as extensively reviewed elsewhere (91–94) it is evident
that therapeutically targeting cytokines may attenuate the
deleterious effects of either acute or chronic insults characterized
by increased cytokine load and subsequent neuroinflammation.
Extending beyond diseases such as stroke, MS, and AD, several
lines of evidence also implicate microglia and cytokines in
neurodevelopmental disorders like autism. For example, a recent
study comparing the transcriptomes of individual cells from the
brains of subjects with autism against non-autistic individuals
identified microglia as the most impacted cell type at the
transcriptomic level (95). In combination with the association of
genetic mutations in neurodevelopmental disorders such as autism
and schizophrenia within and near immune-related genes, most
notably the MHC locus (96), such transcriptional studies support a
role for immune signaling in these disorders. As the fundamental
basis of microglial and cytokine function in the healthy brain is
uncovered, it will be important to extend studies tomousemodels of
human disease and to human tissue in order to understand how
cytokines may be aberrantly employed in the unhealthy brain to
unravel neural wiring and derail neurological function. A better
understanding of the relationship between cytokines and neural
activity has the potential to not only expand what is known about
themolecular basis of brain function in health but also to reveal core
mechanisms of human neurological disease.AUTHOR CONTRIBUTIONS
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